Astex Pharmaceuticals, Inc (ASTX) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 48 transactions totaling $1.1M, demonstrating a bearish sentiment with -$1.1M in net insider flow. The most recent transaction on Oct 11, 2013 involved a transaction of 13,900 shares valued at $0.
No significant insider buying has been recorded for ASTX in the recent period.
No significant insider selling has been recorded for ASTX in the recent period.
Based on recent SEC filings, insider sentiment for ASTX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$1.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Astex Pharmaceuticals, Inc (ASTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading ASTX stock, having executed 48 transactions in the past 90 days. The most active insider is James S. J. Manuso (Executive), who has made 9 transactions totaling $984.4K.
Get notified when executives and directors at ASTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 11, 2013 | S. J. Manuso James | Executive | Tender | 13,900 | $N/A | $0 | |
| Oct 11, 2013 | S. J. Manuso James | Executive | Tender | 70 | $N/A | $0 | |
| Oct 11, 2013 | Jhoti Harren | Executive | Tender | 45,163 | $N/A | $0 | |
| Oct 11, 2013 | Jhoti Harren | Executive | Tender | 16,084 | $N/A | $0 | |
| Oct 11, 2013 | Azab Mohammad | Executive | Tender | 8,753 | $N/A | $0 | |
| Oct 11, 2013 | Buckland Martin | Executive | Tender | 5,963 | $N/A | $0 | |
| Oct 11, 2013 | Molkentin Michael | Executive | Tender | 28,874 | $N/A | $0 | |
| Oct 11, 2013 | Girardi Thomas V | Executive | Tender | 348,500 | $N/A | $0 | |
| Oct 11, 2013 | J. Lack Walter | Executive | Tender | 457,500 | $N/A | $0 | |
| Sep 4, 2013 | S. J. Manuso James | Executive | Option Exercise | 7,500 | $5.69 | $42.7K | |
| Jun 14, 2013 | Jhoti Harren | Executive | Gift | 16,084 | $N/A | $0 | |
| Jun 14, 2013 | Jhoti Harren | Executive | Gift | 16,084 | $N/A | $0 | |
| May 17, 2013 | Girardi Thomas V | Executive | Option Exercise | 75,000 | $4.03 | $302.3K | |
| May 14, 2013 | S. J. Manuso James | Executive | Sale | 29,500 | $5.84 | $172.3K | |
| May 14, 2013 | S. J. Manuso James | Executive | Option Exercise | 29,500 | $4.03 | $118.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 28 | $1.5M | 58.3% |
Sale(S) | 7 | $1.1M | 41.7% |
Tender(U) | 9 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at Astex Pharmaceuticals, Inc has increased, with 8 insiders executing 48 transactions across all time. Total sales of $1.1M significantly outpace purchases of $0, resulting in a net outflow of $1.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.